This collection contains guidelines, forms and documents related to accessing eculizumab (Soliris®) under the Life Saving Drugs Program. Click to view the Soliris® product information on the Therapeutic Goods Administration website.
Fact sheets on changes to eculizumab
Medicines review documents
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.